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Abstract
Artificial intelligence and medicine have a longstanding and proficuous relation-
ship. In the present work we develop a brief assessment of this relationship with
specific focus on machine learning, in which we highlight some critical points
which may hinder the use of machine learning techniques for clinical diagnosis
and therapy advice in practice. We then suggest a conceptual framework to
build successful systems to aid clinical diagnosis and therapy advice, grounded
on a novel concept we have coined drifting domains. We focus on oncology to
build our arguments, as this area of medicine furnishes strong evidence for the
critical points we take into account here.
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Highlights:
• The relationship between Artificial Intelligence and Medicine is reviewed,
highlighting the reasons why few research projects in this field are brought
to medical practice.
• Focusing on supervised learning applied to diagnosis and therapy plan in
oncology, we discuss possible means to overcome this issue.
• We present how existing results related to sample complexity in machine
learning can be brought to this context to become guidelines to structure
and explore results of clinical trials.
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• We introduce the concept of drifting domains as a tool to refine and fine
tune the analysis of results obtained with classification learning in our
domain of interest.
1. Introduction
Artificial intelligence and medicine have a longstanding and proficuous re-
lationship, possibly started with the development of the MYCIN system in the
early 70s for therapy advice [9].
Medicine has provided the field of artificial intelligence with a plethora of
challenging and appealing problems to be solved, particularly in clinical diag-
nosis (“given a set of signs collected from a patient, select the best diagnosis”)
and in therapy advice (“given an established diagnosis, select the best course
of actions for treatment”). Artificial intelligence, in turn, has offered promising
technologies for problem solving in the medical domain [7].
The field of oncology has proven to be particularly fit for modelling and
analysis based on artificial intelligence, at least prospectively [5, 3], due to two
major reasons:
1. Symptoms in oncology are frequently difficult to identify before later
stages of the disease, and cancer can be treated most effectively if iden-
tified at early stages of development. Signs of the disease can be diffuse
and require high expertise to be selected, collected and analysed. Hence,
technologies that can highlight evidence of cancer at early stages are most
welcome and challenging at the same time.
2. Therapy in oncology can be frequently highly aggressive, as it can be based
on drugs which feature high toxicity and/or radiotherapy, which has severe
side effects. Hence, technologies that can either refine therapy plans at a
personal level to minimise side effects or provide unequivocal evidence of
the efficacy of novel therapies are also most welcome.
The practical use of artificial intelligence in medicine, however, has occurred
more often in the management of supporting information, rather than in the
direct support of the activities of healthcare professionals: medical doctors have
been able to augment their capabilities with the support of systems for knowl-
edge representation and processing, as well as automated assistants to process
large data chunks aid decision making. However, the practice of automated
diagnosis and therapy advice has hardly moved outwith research laboratories to
reach everyday activities [1]. Some issues can explain why this has happened:
• Medicine is strongly regulated by specialised organisations such as the
Food and Drug Administration in the US and the European Medicines
Agency and CE Mark certifying bodies in the European Economic Area.
The levels of detail and transparency required for the description of meth-
ods and techniques to be certified by these organisations has proven to be
hard, costly and time consuming to achieve, and the effort to reach such
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levels in the description of novel techniques frequently stays beyond the
scope of academic initiatives.
• Empirical validation of novel methods and techniques for automated di-
agnosis and therapy advice requires clinical trials which are highly costly,
labour and time consuming. In the medical domain, clinical trials are a re-
quired practice for risk mitigation and trust building. Similar procedures
are not usual in computer science, and the mismatch in required costs
and resources sets apart research initiatives from within the contexts of
medical sciences and computer science.
In order to bridge the gap between laboratory experimentation and practice
in the use of artificial intelligence technologies for clinical diagnosis and therapy
advice, these issues must be faced.
In recent years, the field of artificial intelligence has steered towards machine
learning, given its significant advances and results [4]. Following this trend, in
the present article we focus on machine learning – more specifically, supervised
classification learning, given that this particularly class of techniques can be
formally characterised and analysed in detail – and how it can be explored to
build systems for automated diagnosis and therapy advice which can be used
in practice. We consider three specific points related to the issues mentioned in
the previous paragraphs:
1. One reason for the recent praise to machine learning has been the claim
that it decreases subjectivity in artificial intelligence, as domain knowledge
and expertise are replaced by statistically grounded data analysis. Critical
aspects of domain modelling, however, are still at the core of systems
development based on machine learning. Accounting for regulatory issues
and transparency requirements, we unveil these aspects and clarify how
and why domain knowledge and human expertise – on the medical domain
as well as on computational and statistical techniques – are central to the
design of systems based on machine learning for the medical issues on
which we are working.
2. The demanding requirements of resources connected to clinical trials in-
crease the relevance of controlling sample complexity (in other words,
extracting as much information as possible from samples which are kept
as small as possible in order to train learning algorithms), which in turn
points to the importance of good domain modelling for the problems we
are considering. For these reasons, we develop a careful analysis of our
population of interest, accounting for the fact that controlled sample cardi-
nality can be key to ensure the feasibility of proposed solutions in practice.
3. Our population of interest features an interesting dynamics of evolution,
which we believe has not been considered in detail in previous initiatives.
We take this dynamics into account and characterise the population as
a drifting domain, in the sense that it is permanently evolving, although
almost always in a smooth rate. We explore how drifting domains can
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be formally characterised to build accurate predictive models based on
classification learning.
The propositions and results presented in this article result from experiments
under development at Autem Medical Research, focusing on the development
of novel technologies for cancer diagnosis and therapy. In this article we fo-
cus on conceptual issues, and refer to our experiments mainly to illustrate our
arguments. In a future article we shall present our empirical results from the
perspective of advances in clinical diagnosis and therapy advice.
In section 2 we characterise a method and model to build systems based on
machine learning for the problems we are considering in medicine, in which we
highlight the importance of domain knowledge and expertise for model design.
In section 3 we discuss specific aspects of our domain of interest, including how
and why we can focus on populations with finite cardinality and how we can
build lower bounds for population cardinality (aka sample complexity) given
our requirements for precision and reliability. In section 4 we characterise our
proposed notion of drifting domains and how it can be used to increase precision
and reliability of our results. Finally, in section 5 we present a discussion and
conclusions.
2. Classification learning for diagnosis and therapy advice
The task of clinical diagnosis can be characterised as a set of steps:
1. An individual patient p comes to the medical doctor. The doctor selects
a set of signs S1 to observe and analyse. The choice of the set S1 is based
on:
• Previous experience and scholarly knowledge.
• Tacit selection of a reference population P , assuming of course that
p ∈ P .
2. Given the observations related to signs S1, the doctor builds a preliminary
set of hypotheses D about the diagnostics of p. These hypotheses are
dependent upon previous experience, scholarly knowledge and the refer-
ence population, which determine an (unknown yet clearly defined) upper
bound on the precision and reliability of diagnostics.
3. Hypotheses are prioritised according to
• strength of evidence indicating each hypothesis, and
• the severity of corresponding diseases.
Following these priorities, for each hypothesis:
(a) A second set of signs S2 is selected. Again, the choice of S2 is based
on previous experience, scholarly knowledge and the reference popu-
lation.
(b) Given the observations related to signs S2, the doctor tags the cor-
responding hypothesis as either possible or discarded.
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4. The medical doctor then proceeds to perform information fusion about all
hypotheses at hand and final decision about diagnostics.
We have focused on the automation of steps 1 to 3 in clinical diagnoses as
outlined in the previous paragraphs. These steps inherently depend upon expert
knowledge, regardless of the computational techniques that can be employed for
automation.
Required general steps to automate this procedure using supervised classifi-
cation learning can be characterised as follows:
1. Given an individual patient p, a reference population P is explicitly char-
acterised, such that p ∈ P .
2. Based on expert knowledge, a set or preliminary signs S1 is selected.
3. An oracle Pˆ ⊆ P containing information about the correlation between
signs in S1 and hypotheses in D for diagnostics for population P is re-
trieved from a database of oracles. An oracle is a collection of pairs 〈~Si, Di〉
in which ~Si ∈ S1 is a tuple of signs and D ∈ {⊤,⊥} is a corresponding
diagnostics as observed in a patient pi ∈ P .
The cardinality of oracle Pˆ (i.e. the number of patients pi ∈ Pˆ ) must be
sufficiently large to ensure appropriate levels of precision and reliability
of diagnostics performed about any patient p ∈ P , which correspond to a
sufficiently large similarity level between empirical classifiers and the best
available classifier as determined by unknown upper bounds provided by
human expertise.
4. The correlation between signs and hypotheses is characterised with re-
spect to a family of functions that best captures how decision procedures
can be optmised for this correlation. In machine learning and statistics
jargon, such families of functions are called kernel functions. The choice
of the appropriate family of kernels (e.g. polynomial, gaussian, sigmoid
etc. [8]) is based on visual inspection of the correlation graphs and expert
knowledge about the methods and techniques used to build models for
machine learning. The choice of a family of kernels determines another
(unknown) upper bound on the precision and reliability of diagnostics.
5. Hypotheses are prioritised and, for each hypothesis, a second set of signs
S2 is selected, based on expert knowledge and the reference population.
6. A second family of kernels is selected given the observed correlation be-
tween S2 and the corresponding hypothesis.
7. Samples of appropriate cardinality are selected from the population P ,
considering lower bounds for the cardinality of samples as a function of
the required precision and reliability of diagnostics that can ensure suffi-
ciently high similarity between empirical classifiers and the best available
classifier. These lower bounds can be characterised based on existing the-
oretical results as detailed in section 3. If a sample has cardinality above
the identified upper bounds, we have statistical guarantees that obtained
classifiers will be, with high probability, sufficiently close to the best avail-
able classifier given the upper bounds determined by the expert choices as
identified in the previous steps.
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8. Automated decision procedures are built for the diagnosis of patient p ∈ P
employing a sample Pˆ of appropriate cardinality and the sets of signs S1
and S2.
9. Decision procedures are employed to build information to support the
medical doctor in diagnostics.
Similarly, the task of therapy advice can be characterised as a set of steps:
1. An individual patient p comes to the medical doctor, featuring a previously
identified most likely diagnostics. The doctor selects a set of tests T to
perform, in order to decide for a therapy plan. As in diagnosis, the set T
is based on:
• Previous experience and scholarly knowledge.
• Tacit selection of a reference population P such that p ∈ P .
2. Given the outcomes of T , the doctor builds a personalised therapy plan
for patient p. This plan can contain additional decision points in the form
of IF-THEN rules.
3. The effectiveness of the treatment is assessed based on empirical observa-
tion of attributes which are determined based on expert knowledge and
the reference population.
General steps to automate this procedure can be characterised as follows:
1. Given a patient p and corresponding most likely diagnostics, and given
the reference population P employed in the analysis, alternative therapy
plans Ti are ranked according to previous empirical results. Ranking is
based on (most likely non-linear) correlation analyses between different
therapy plans and their corresponding effective measurements, which are
built using samples Pˆ ⊆ P of appropriate cardinality, which must be
such that precision and reliability can be ensured with respect to the best
available information about therapy plans. The best available information
about different plans, in turn, is based on a history of empirical results.
In oncology, given the high mortality related to certain types of tumour,
these empirical results can be based on relatively small numbers of cases
which are,in turn, described in great detail.
2. The most highly ranked therapy is selected and applied on p.
This characterisation of both clinical diagnosis and therapy advice as sets
of steps aims at the identification of the issues that impose limitations on the
precision and reliability of diagnosis and therapy advice:
• The choice of the sets of signs S1 and S2, as well as the set of therapy
plans T depends upon previous experience and scholarly knowledge (expert
knowledge).
• The choice of the reference population P to ground analyses also depends
on expert knowledge.
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• The choice of the family of kernels to characterise the correlations between
signs and hypotheses, as well as between diagnostics and therapy plans,
depends upon experience and scholarly knowledge about statistical be-
haviour of specified random variables with respect to stochastic decision
procedures in the domain of interest.
These limitations are imposed upon the best possible decision procedures
for patients in the population P . Additionally,
• The cardinality of the samples used to build empirical estimates for the
best possible decision procedures is determined given lower bounds pro-
vided by statistical analysis.
Explicit account of these limitations and their reasons are useful to clarify
that:
1. Most limitations in the quality of automated clinical diagnosis and ther-
apy advice originate from previous experience of medical doctors, schol-
arly knowledge and the reference population employed to make decisions.
These issues are not particular to automated systems and are at place in
standard medical practice.
2. Limitations in precision and reliability of decisions due to sample cardinal-
ity can be safely bounded provided that we have access to sufficiently large
samples. These bounds, as detailed in the following section, are grounded
on scrutinous mathematical analysis.
Moreover,
3. The dynamics of reference populations can be modelled and taken into
account explicitly in decision procedures. In section 4 we introduce a
methodology to provide bounds in precision of decisions given heuristic
estimates of the dynamics of the evolution of reference populations.
In the following sections we discuss in detail the lower bounds for the cardi-
nality of samples Pˆ ⊆ P to estimate decision procedures, as well as the dynamics
of the reference populations P .
3. Domain characterisation
The initial problem we consider, as characterised in the previous sections, is
as follows: given a reference population P of patients featuring sufficiently high
homogeneity with respect to the correlation between observable signs ∈ S and
corresponding diagnoses ∈ D, we wish to determine a minimal cardinality N
for oracles Pˆ of the form Pˆ = {〈~v1, di〉, . . . , 〈~vN , dN 〉} such that for the indices
1, . . .N we have that p1, . . . pN ∈ P , each ~vi is a tuple of values of signs ∈ S
corresponding to observations about patient pi, and di ∈ {⊤,⊥} is a confirmed
diagnostics for patient pi with respect to a disease d ∈ D, in which ⊤ indicates
confirmed disease and ⊥ indicates refuted disease.
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We assume a high correlation between values of signs ~vi and diagnostics
di. We do not assume, however, that this correlation is perfect (which would
correspond to a fully deterministic power, at least in a theoretical limit in which
information about all patients in P is available, to diagnose disease di given
observed values of signs ~vi). The set {〈~v1, d1〉, . . . , 〈~v|P |, d|P |} of all pairs 〈signs,
diagnostics〉 ∈ P can, therefore, be partially inconsistent, amounting for an
(unknown yet determined) upper bound on the precision of diagnoses as well
as definition of therapy plans. This upper bound determines the best available
classifiers. Our task is to build empirical classifiers based on oracles Pˆ which
are provably sufficiently similar to the best available classifiers.
The theory of Probably Approximately Correct Learning [10], as further ex-
tended to cope with partial inconsistencies [2, 6], can provide us with lower
bounds for the cardinality of ~P as a function of:
• |~V|: the cardinality of the valued signs space. Assuming that each sign
s ∈ S can have a finite set of values {v1, . . . , vns} with cardinality ns, we
have that |~V| =
∏
s∈S ns.
• ǫ: precision, determined as an upper bound for the acceptable disagree-
ment between an empirical classifier and the best available classifier. For
example, if ǫ = 0.1, then the probability that, given a tuple of values of
signs ~v, the empirical classifier and the best available classifier provide the
same diagnostics d ∈ {⊤,⊥} is at least 90%.
• δ: reliability, as an upper bound for the risk to build a classifier whose
precision parameter is above the specified value ǫ. For example, if δ = 0.2
and ǫ = 0.1, then there is a probability below 20% to select a random
classifier built using any oracle Pˆ with a disagreement below 90% with
respect to the best available classifier.
Following [6], we can define a lower bound for the cardinality of Pˆ (denoted
as |Pˆ |) as:
|~P | ≥
(ln|~V|+ln 2
δ
)
2ǫ2
The same lower bound applies for diagnosis and for therapy advice, if we
use, for example, Support Vector Classification for diagnosis and Support Vector
Correlation for therapy advice [6].
As an example, assuming |~V| ≈ 150, we will have ln|~V| ≈ 5. This is a
realistic assumption, considering the number of parameters and corresponding
values which are usually considered by a medical doctor for the tasks under
consideration here.
Employing this value, estimates can be obtained for |~P | given values for ǫ
and δ as presented in Table 1.
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|Pˆ |
ǫ
0.1 0.2 0.3
δ
0.1 400 366 346
0.2 100 92 87
0.3 45 41 39
Table 1: Lower bounds for |~P | given ǫ and δ assuming |~V| ≈ 150.
As a concrete illustration, according to Table 1, if we wish to have a prob-
ability below 20% that a classifier will be built with disagreement above 10%
with respect to the best available classifier, then we need to have access to a
reference population with at least 100 patients.
These results bring existing methods and techniques to the context of clin-
ical diagnosis and therapy advice, and provide medical doctors with concrete
parameters and specifications to allow the development of systems based on clas-
sification learning for direct support of their activities. They are based, however,
on an implicit assumption that any reference population and corresponding or-
acles for any disease under consideration are static. This assumption is not
observed in practice:
• Patients pass away, and new patients appear all the time.
• Environmental factors (e.g. pollution rates, dietary habits, stress levels)
affect the reference population and the extent to which observed signals
correlate with diagnoses.
For these reasons, it is reasonable to assume that the reference population
undergoes small updates all the time. In order to take into account these up-
dates, we introduce in the next section the concept of drifting domains and show
how it can be employed to build more refined and precise estimates for clinical
diagnosis and therapy advice.
4. Drifting domains
Some implicit assumptions about our domain have been used in the previous
sections:
1. Our domain is finite, even though it can be large. This way, technical
assumptions about probability distributions and logical deductions can be
simplified respectively to discrete distributions and propositional reason-
ing.
2. Our domain is static and fixed, even though we may not have complete
information about each and every element of the domain.
We challenge the second assumption, given our previous consideration that
our domain of interest undergoes permanent updates. We assume that these
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updates are gradual and smooth, as we believe that this assumption is realistic
and it simplifies our analyses.
In order to characterise this assumption, we denote domains in which these
characteristics are found drifting domains. A drifting domain is, therefore:
• A finite domain whose cardinality can be unknown and is permanently
updated with small random values which can be positive or negative.
• Such that a fixed set of signs characterise each and all elements in the
domain.
• Such that each sign admits a finite set of values.
• Such that the value of each sign associated to each element in the domain
is permanently updated, in such way that no “sudden jump” in a value
can be observed.
Given these assumptions, and considering that an undetermined time in-
terval occurs between data is collected to build oracles, and that oracles are
used for classification of patients, then one reasonable strategy to build more
accurate oracles is to assume that, for each value of each sign collected from a
patient, the actual present value of that sign can be a different value “around”
the observed value.
One possible way to formalise this strategy is to assume that, for each ob-
served value of a sign, the actual present value is going to be within an interval
centred in the observed value. In order to keep calculations simple, we can
assume a probability distribution around the observed value, such as e.g. a
standardised normal distribution in which the mean value is the observed value.
If, additionally, all values are assumed to be discrete approximations of real
scalar values, we can further assume that present the values of a sign are, with
high probability (above 95%), within two standard deviations below and above
the observed value.
This way, for each observed value v˜ we build the interval [v˜−, v˜+] such that
v˜− = v˜−2σ and v˜+ = v˜+2σ. If we consider the extreme values in this interval,
we have for each observed value v˜ the two values {v˜−, v˜+}.
Given |S| as the cardinality of the set of signs, and given one specific obser-
vation about one patient belonging to an oracle, reasoning based on extremes
of a surrounding interval for the value of each sign builds 2|S| alternative “ver-
sions” of that observation. Assuming that the cardinality of a sample is |Pˆ |, we
then have a collection of “possible worlds” W whose cardinality is defined as:
|W| = |Pˆ |2|S|
If we build one empirical classifier for each possible world, we can test the
observations of a new patient with respect to |W| different classifiers. Two
possibilities can occur:
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1. All classifiers agree on the diagnostics for the patient. In this case, this
diagnostics is strengthened by being tested considering all variations of
the observed sample given the drifting domain under consideration.
2. We obtain conflicting classifiers across the possible worlds. In this case,
upon final decision of the medical doctor, three different strategies can be
considered:
(a) Cautious strategy: the doctor concludes that data is inconsistent
and/or insufficient for decision and requires a second cycle of ob-
servations, selection of a reference population etc. hoping to be able
to resolve the conflict.
(b) Asymmetric strategy: in diagnosis false negatives can be more harm-
ful than false positives, i.e. it can be more damaging to diagnose
an unhealthy patient as healthy than the opposite. In this case, if
at least one classifier diagnoses the patient as unhealthy, following
this strategy the patient can be taken for further examination as
potentially unhealthy.
(c) Uncertainty-based strategy: some heuristics can be built to assess un-
certainty degrees corresponding to the conflicting outcomes of clas-
sifiers. For example, some voting procedure can be adopted, such
that the confidence on a diagnostics is based on the proportion of
classifiers that indicate that diagnostics.
For diagnosis, any of the three strategies can be adopted. For therapy ad-
vice, however, only the first strategy makes sense, given that the selection
of the wrong therapy plan is potentially harmful in a symmetric way.
5. Conclusion
In this article we have built considerations on how to close the gap between
laboratory experimentation and medical practice on using classification learning
for clinical diagnosis and therapy advice, with a specific focus on oncology.
More specifically, we have provided an explicit and detailed account of how
systems for classification learning can be inserted into the activities workflow
of a medical doctor to support diagnosis and therapy advice. Given that an
important barrier to the application of machine learning techniques in medicine
can be the requirements of large volumes of data, which can point to the ne-
cessity of building and running prohibitively costly clinical trials, we have also
developed an analysis of sample complexity estimates to build oracles to train
systems based on supervised learning, and suggested a pathway to build ora-
cles based on clinical trials of viable dimensions. Finally, we have considered
the dynamics of populations from which samples can be taken, and proposed
a strategy to refine the analysis of classification results that take into account
this dynamics, based on a proposed notion of drifting domains.
The considerations we have built here are based on actual experiments un-
der development at Autem Medical Research, where we have worked on novel,
lesser aggressive therapies for certain types of cancer and on novel, non-invasive,
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speedy and low cost technologies for early diagnosis of cancer. Following the
guidelines presented here, we have been able to build classifiers to make diag-
nosis with error rates below 25% based on oracles such that |Pˆ | ≤ 90. These
classifiers are, at present, undergoing scrutinous analysis and shall be described
in a specific article in the near future.
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